Prenatal diagnosis of homozygous a thalassaemia was performed in eight successive patients at risk using DNA from uncultured amniotic fluid cells. The presence of a gene was determined by restriction endonuclease mapping and hybridisation with cloned a and l globin probes.
Introduction
Homozygous a thalassaemia which presents as haemoglobin Barts hydrops fetalis arises from the deletion of all four a globin structural genes.' -This condition is more common in South East Asia owing to the higher prevalence of a thalassaemia 1 (--/aa) in this area than in the Mediterranean region and Africa.4 5The affected fetus usually dies in utero between 23 and 38 weeks of pregnancy or soon after birth. 6 Despite the invariably fatal consequences of the homozygous state early diagnosis is still desirable, since these pregnancies are often complicated by pre-eclampsia, with significant maternal morbidity and mortality.7 Wong et al first employed liquid hybridisation of DNA from cultured amniotic fluid cells for prenatal diagnosis of homozygous a thalassaemia. With the development of restriction endonucleases and Southern blotting, direct performed at 16 weeks of gestation enough DNA may be isolated from amniotic fluid cells without the need for culture.'0 We report our preliminary experience of prenatal diagnosis for homozygous a thalassaemia using direct DNA analysis.
Subjects, materials, and methods
Over two months eight pregnant Chinese women with a history of delivery of an infant with haemoglobin Barts hydrops fetalis requested prenatal diagnosis. All except one were in the second trimester (16- Prenatal diagnosis of homozygous a thalassaemia is still not available in most parts of South East Asia, and for these regions ultrasonography may be used as an alternative to detect hydrops fetalis.'7 Although it is sometimes possible to detect ascites and hydropic changes before the 24th week, however, these are not always evident: in our case 3 no ultrasound abnormalities were observed even at 34 weeks. Since amniotic fluid cells may be frozen and shipped to laboratories, amniocentesis and prenatal diagnosis should be offered to couples at risk. 
Patients and methods
Fetal blood flow was examined in six women with uncomplicated pregnancies who were to be delivered by elective caesarean section. The indications for caesarean section were cephalopelvic disproportion in five cases and the age of the mother in one (she was a 42 year old primigravida). All of the women gave their informed consent.
The blood flow in the fetal descending aorta and the intra-abdominal part of the umbilical vein was examined with a 2 MHz pulsed Doppler technique combined with real time B mode ultrasonography.' The mean blood flow was calculated and the waveform of the maximum blood velocity analysed. The waveform was characterised by the pulsatility index (=(peak velocity-minimum velocity)/ mean velocity).3 The measurements were performed with the pregnant woman tilted slightly to the left (150) to avoid hypotension. Fetal heart rate and the maternal pulse rate and blood pressure were also measured. Fetal blood flow was recorded before the induction of epidural analgesia and 15 and 30 minutes thereafter.
After preloading with 0-5 1 of a balanced electrolyte solution analgesia was induced at the L3-4 interspace using 10 ml etidocaine 15% and 10-12 ml bupivacaine 0 5% both containing adrenaline (5 Mg/ml). Cutaneous analgesia up to the level of T7 and T5 ensued after 15 and 30 minutes, respectively.
The women were then delivered by caesarean section. The infants had a mean gestational age of 38-2 (SEM 0-3) weeks, a mean birth weight of 3388 (194) g, a mean umbilical arterial pH of 7-22 (0 02), and a mean umbilical venous pH of 7-28 (0-02). The one minute Apgar score was > 8 in all of them.
Results
The table gives the mean values of the maternal and fetal circulatory variables. In no instance was the maternal systolic blood pressure lower than 100 mm Hg. The mean blood velocity and the diameters of the fetal aorta and umbilical vein were within the normal range before analgesia in all six fetuses and did not change during the study period. The figure shows the fetal aortic and umbilical blood flows; no appreciable change in fetal blood flow was observed.
